See the Full Picture.
Published loading...Updated

FDA Clears ZEISS INTRABEAM 700 for Intraoperative Radiation Therapy in Neuro-Oncology & Breast Cancer

Summary by onclive.com
The ZEISS INTRABEM 700 platform received 510(k) clearance from the FDA for use in neuro-oncology and breast cancer surgery.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All
Left
Center
Right

They are the therapeutic drugs, which eliminate the tumor after being identified and therefore have therapeutic and diagnostic utility. They work as a very specific internal radiation therapy: instead of eliminating the tumor by irradiating from the outside, exposing much of the body, lethal radiation is guided within the body directly to tumor cells. The strategy is already used to treat some tumors and is an area of research that is booming.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CNIO broke the news in on Wednesday, April 9, 2025.
Sources are mostly out of (0)